Nalaganje...

HAF mediates the evasive resistance of anti-angiogenesis TKI through disrupting HIF-1α and HIF-2α balance in renal cell carcinoma

Anti-angiogenesis has emerged as a standard of care for metastatic renal cell carcinoma. However, long-lasting efficacy is seldom reached, and evasive resistance eventually occurs under anti-angiogenic tyrosine kinase inhibitor (TKI) therapy. To establish new therapeutic strategies, investigating th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Lai, Xiang-Me, Liu, Shu-Yu, Tsai, Yi-Ta, Sun, Guang-Huan, Chang, Sun-Yran, Huang, Shih-Ming, Cha, Tai-Lung
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564801/
https://ncbi.nlm.nih.gov/pubmed/28572533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17923
Oznake: Označite
Brez oznak, prvi označite!